Approach of primary care physicians to hepatitis C: an educational survey from a Southern Italian area

J Infect. 2005 Dec;51(5):396-400. doi: 10.1016/j.jinf.2004.12.004. Epub 2005 Jan 21.

Abstract

Objectives: To assess knowledge, attitudes and practices towards hepatitis C of primary care physicians (PCPs) working in a Southern Italian area.

Methods: A questionnaire exploring the basic knowledge on risk factors and the management of hepatitis C virus infection was administered in two occasions to a sample of PCPs before and 2 months later the presentation of the EASL guidelines on the management of HCV infection.

Results: At the first survey, drug addiction, transfusion in 1982 and sexual contact with multiple partners were listed as the most common risk factors for acquiring HCV infection. As many as 27% of PCPs believed that blood transfusion after 1994 was still an important risk factor for this infection. Only 38% of PCPs would refer HCV positive subject with abnormal ALT levels to a gastroenterologist. Some points showed a definite improvement when first and second survey were compared: the more frequent use of qualitative instead of quantitative HCV-RNA testing for diagnostic purpose and the selection of IFN plus ribavirin as the regimen of choice for active disease.

Conclusions: The general practice management of hepatitis C may be improved using educational activities involving directly and interactively PCPs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use
  • Attitude of Health Personnel
  • Clinical Competence
  • Education, Medical, Continuing*
  • Guideline Adherence
  • Health Care Surveys
  • Hepatitis C / diagnosis
  • Hepatitis C / therapy*
  • Humans
  • Interferons / therapeutic use
  • Italy
  • Practice Guidelines as Topic / standards
  • Practice Patterns, Physicians'*
  • Primary Health Care*
  • RNA, Viral / isolation & purification
  • Ribavirin / therapeutic use
  • Risk Factors

Substances

  • Antiviral Agents
  • RNA, Viral
  • Ribavirin
  • Interferons